Antibody-based cancer immunotherapy by targeting regulatory T cells.

Li Q, Lu J, Li J, Zhang B, Wu Y, Ying T

DOI: 10.3389/fonc.2023.1157345
Published: 2023
Container: Frontiers in oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2023.1157345,
  title = {Antibody-based cancer immunotherapy by targeting regulatory T cells.},
  author = {Li Q and Lu J and Li J and Zhang B and Wu Y and Ying T},
  year = {2023},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2023.1157345},
  url = {https://doi.org/10.3389/fonc.2023.1157345}
}

RIS

TY  - JOUR
TI  - Antibody-based cancer immunotherapy by targeting regulatory T cells.
AU  - Li Q
AU  - Lu J
AU  - Li J
AU  - Zhang B
AU  - Wu Y
AU  - Ying T
PY  - 2023
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2023.1157345
UR  - https://doi.org/10.3389/fonc.2023.1157345
ER  -

APA

Q, L., J, L., J, L., B, Z., Y, W., & T, Y. (2023). Antibody-based cancer immunotherapy by targeting regulatory T cells.. Frontiers in oncology. https://doi.org/10.3389/fonc.2023.1157345

Source records

pubmed · retrieved 2026-09-26T21:00:09.911Z